BackInozyme Pharma Overview

Inozyme Pharma Common Stock

Track Inozyme Pharma's common stock ($6K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$6000.00
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Inozyme Pharma Common Stock History

Loading

Inozyme Pharma vs. peers: Common Stock Comparison

Loading

Inozyme Pharma Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Inozyme Pharma (INZY) FAQ

As of the most recent data (March 2025), INZY shows a common stock of $6K. That compares with $6K in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INZY's common stock is now $6K (was $6K) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Inozyme Pharma is outperforming or lagging.

Tracking INZY's common stock over time shows whether Inozyme Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $6K That compares with $6K in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Inozyme Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $6K) with ownership activity and broader fundamentals.

Inozyme Pharma's common stock is $6K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.